Danish pharma giant Novo Nordisk has ended its partnership with US-based telehealth firm Hims & Hers Health Inc., citing concerns over “deceptive marketing” of copycat versions of its obesity treatment Wegovy.
Source: https://www.bloomberg.com/news/articles/2025-06-23/novo-exits-hims-hers-partnership-citing-compounding-concerns